LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 219

Search options

  1. Article ; Online: Weaponizing the proteasome to overcome antimalarial drug resistance.

    Xiao, Zhangping / Gray, Janine L / Tate, Edward W

    Cell chemical biology

    2023  Volume 30, Issue 5, Page(s) 415–417

    Abstract: In this issue of Cell Chemical Biology, Zhan et al. report dual-pharmacophore molecules ("artezomibs"), combining an artemisinin and proteasome inhibitor that exhibit potent activity against both wild-type and drug-resistant malarial parasites. ...

    Abstract In this issue of Cell Chemical Biology, Zhan et al. report dual-pharmacophore molecules ("artezomibs"), combining an artemisinin and proteasome inhibitor that exhibit potent activity against both wild-type and drug-resistant malarial parasites.
    MeSH term(s) Antimalarials/chemistry ; Proteasome Endopeptidase Complex ; Drug Resistance ; Proteasome Inhibitors/pharmacology ; Proteasome Inhibitors/chemistry
    Chemical Substances Antimalarials ; Proteasome Endopeptidase Complex (EC 3.4.25.1) ; Proteasome Inhibitors
    Language English
    Publishing date 2023-05-17
    Publishing country United States
    Document type Journal Article ; Comment
    ISSN 2451-9448
    ISSN (online) 2451-9448
    DOI 10.1016/j.chembiol.2023.04.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Proteome-wide structural analysis identifies warhead- and coverage-specific biases in cysteine-focused chemoproteomics.

    White, Matthew E H / Gil, Jesús / Tate, Edward W

    Cell chemical biology

    2023  Volume 30, Issue 7, Page(s) 828–838.e4

    Abstract: Covalent drug discovery has undergone a resurgence over the past two decades and reactive cysteine profiling has emerged in parallel as a platform for ligand discovery through on- and off-target profiling; however, the scope of this approach has not been ...

    Abstract Covalent drug discovery has undergone a resurgence over the past two decades and reactive cysteine profiling has emerged in parallel as a platform for ligand discovery through on- and off-target profiling; however, the scope of this approach has not been fully explored at the whole-proteome level. We combined AlphaFold2-predicted side-chain accessibilities for >95% of the human proteome with a meta-analysis of eighteen public cysteine profiling datasets, totaling 44,187 unique cysteine residues, revealing accessibility biases in sampled cysteines primarily dictated by warhead chemistry. Analysis of >3.5 million cysteine-fragment interactions further showed that hit elaboration and optimization drives increased bias against buried cysteine residues. Based on these data, we suggest that current profiling approaches cover a small proportion of potential ligandable cysteine residues and propose future directions for increasing coverage, focusing on high-priority residues and depth. All analysis and produced resources are freely available and extendable to other reactive amino acids.
    MeSH term(s) Humans ; Cysteine/metabolism ; Proteome/metabolism ; Amino Acids ; Drug Discovery ; Ligands
    Chemical Substances Cysteine (K848JZ4886) ; Proteome ; Amino Acids ; Ligands
    Language English
    Publishing date 2023-07-13
    Publishing country United States
    Document type Meta-Analysis ; Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2451-9448
    ISSN (online) 2451-9448
    DOI 10.1016/j.chembiol.2023.06.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets.

    Tate, Edward W / Soday, Lior / de la Lastra, Ana Losada / Wang, Mei / Lin, Hening

    Nature reviews. Cancer

    2024  Volume 24, Issue 4, Page(s) 240–260

    Abstract: Protein lipidation describes a diverse class of post-translational modifications (PTMs) that is regulated by over 40 enzymes, targeting more than 1,000 substrates at over 3,000 sites. Lipidated proteins include more than 150 oncoproteins, including ... ...

    Abstract Protein lipidation describes a diverse class of post-translational modifications (PTMs) that is regulated by over 40 enzymes, targeting more than 1,000 substrates at over 3,000 sites. Lipidated proteins include more than 150 oncoproteins, including mediators of cancer initiation, progression and immunity, receptor kinases, transcription factors, G protein-coupled receptors and extracellular signalling proteins. Lipidation regulates the physical interactions of its protein substrates with cell membranes, regulating protein signalling and trafficking, and has a key role in metabolism and immunity. Targeting protein lipidation, therefore, offers a unique approach to modulate otherwise undruggable oncoproteins; however, the full spectrum of opportunities to target the dysregulation of these PTMs in cancer remains to be explored. This is attributable in part to the technological challenges of identifying the targets and the roles of protein lipidation. The early stage of drug discovery for many enzymes in the pathway contrasts with efforts for drugging similarly common PTMs such as phosphorylation and acetylation, which are routinely studied and targeted in relevant cancer contexts. Here, we review recent advances in identifying targetable protein lipidation pathways in cancer, the current state-of-the-art in drug discovery, and the status of ongoing clinical trials, which have the potential to deliver novel oncology therapeutics targeting protein lipidation.
    MeSH term(s) Humans ; Protein Processing, Post-Translational ; Neoplasms/drug therapy ; Phosphorylation ; Transcription Factors ; Oncogene Proteins
    Chemical Substances Transcription Factors ; Oncogene Proteins
    Language English
    Publishing date 2024-02-29
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2062767-1
    ISSN 1474-1768 ; 1474-175X
    ISSN (online) 1474-1768
    ISSN 1474-175X
    DOI 10.1038/s41568-024-00666-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Dynamics and Molecular Interactions of GPI-Anchored CD59.

    Voisin, Tomas B / Couves, Emma C / Tate, Edward W / Bubeck, Doryen

    Toxins

    2023  Volume 15, Issue 7

    Abstract: CD59 is a GPI-anchored cell surface receptor that serves as a gatekeeper to controlling pore formation. It is the only membrane-bound inhibitor of the complement membrane attack complex (MAC), an immune pore that can damage human cells. While CD59 blocks ...

    Abstract CD59 is a GPI-anchored cell surface receptor that serves as a gatekeeper to controlling pore formation. It is the only membrane-bound inhibitor of the complement membrane attack complex (MAC), an immune pore that can damage human cells. While CD59 blocks MAC pores, the receptor is co-opted by bacterial pore-forming proteins to target human cells. Recent structures of CD59 in complexes with binding partners showed dramatic differences in the orientation of its ectodomain relative to the membrane. Here, we show how GPI-anchored CD59 can satisfy this diversity in binding modes. We present a PyLipID analysis of coarse-grain molecular dynamics simulations of a CD59-inhibited MAC to reveal residues of complement proteins (C6:Y285, C6:R407 C6:K412, C7:F224, C8β:F202, C8β:K326) that likely interact with lipids. Using modules of the MDAnalysis package to investigate atomistic simulations of GPI-anchored CD59, we discover properties of CD59 that encode the flexibility necessary to bind both complement proteins and bacterial virulence factors.
    MeSH term(s) Humans ; Complement Membrane Attack Complex/metabolism ; Complement System Proteins ; CD59 Antigens/chemistry ; CD59 Antigens/metabolism ; Bacteria/metabolism
    Chemical Substances Complement Membrane Attack Complex ; Complement System Proteins (9007-36-7) ; CD59 Antigens ; CD59 protein, human (101754-01-2)
    Language English
    Publishing date 2023-06-30
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2518395-3
    ISSN 2072-6651 ; 2072-6651
    ISSN (online) 2072-6651
    ISSN 2072-6651
    DOI 10.3390/toxins15070430
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: XerC Is Required for the Repair of Antibiotic- and Immune-Mediated DNA Damage in Staphylococcus aureus.

    Ledger, Elizabeth V K / Lau, Katie / Tate, Edward W / Edwards, Andrew M

    Antimicrobial agents and chemotherapy

    2023  Volume 67, Issue 3, Page(s) e0120622

    Abstract: To survive in the host environment, pathogenic bacteria need to be able to repair DNA damage caused by both antibiotics and the immune system. The SOS response is a key bacterial pathway to repair DNA double-strand breaks and may therefore be a good ... ...

    Abstract To survive in the host environment, pathogenic bacteria need to be able to repair DNA damage caused by both antibiotics and the immune system. The SOS response is a key bacterial pathway to repair DNA double-strand breaks and may therefore be a good target for novel therapeutics to sensitize bacteria to antibiotics and the immune response. However, the genes required for the SOS response in Staphylococcus aureus have not been fully established. Therefore, we carried out a screen of mutants involved in various DNA repair pathways to understand which were required for induction of the SOS response. This led to the identification of 16 genes that may play a role in SOS response induction and, of these, 3 that affected the susceptibility of S. aureus to ciprofloxacin. Further characterization revealed that, in addition to ciprofloxacin, loss of the tyrosine recombinase XerC increased the susceptibility of S. aureus to various classes of antibiotics, as well as to host immune defenses. Therefore, the inhibition of XerC may be a viable therapeutic approach to sensitize S. aureus to both antibiotics and the immune response.
    MeSH term(s) Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/metabolism ; Staphylococcus aureus ; Ciprofloxacin/pharmacology ; Ciprofloxacin/metabolism ; DNA Damage/genetics ; DNA Repair/genetics
    Chemical Substances Anti-Bacterial Agents ; Ciprofloxacin (5E8K9I0O4U)
    Language English
    Publishing date 2023-02-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/aac.01206-22
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Bacterial enzymes: powerful tools for protein labeling, cell signaling, and therapeutic discovery.

    Liu, Lu / Gray, Janine L / Tate, Edward W / Yang, Aimin

    Trends in biotechnology

    2023  Volume 41, Issue 11, Page(s) 1385–1399

    Abstract: Bacteria have evolved a diverse set of enzymes that enable them to subvert host defense mechanisms as well as to form part of the prokaryotic immune system. Due to their unique and varied biochemical activities, these bacterial enzymes have emerged as ... ...

    Abstract Bacteria have evolved a diverse set of enzymes that enable them to subvert host defense mechanisms as well as to form part of the prokaryotic immune system. Due to their unique and varied biochemical activities, these bacterial enzymes have emerged as key tools for understanding and investigating biological systems. In this review, we summarize and discuss some of the most prominent bacterial enzymes used for the site-specific modification of proteins, in vivo protein labeling, proximity labeling, interactome mapping, signaling pathway manipulation, and therapeutic discovery. Finally, we provide a perspective on the complementary advantages and limitations of using bacterial enzymes compared with chemical probes for exploring biological systems.
    Language English
    Publishing date 2023-06-14
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 47474-5
    ISSN 1879-3096 ; 0167-7799
    ISSN (online) 1879-3096
    ISSN 0167-7799
    DOI 10.1016/j.tibtech.2023.05.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Photoactive Bifunctional Degraders: Precision Tools To Regulate Protein Stability.

    Kounde, Cyrille S / Tate, Edward W

    Journal of medicinal chemistry

    2020  Volume 63, Issue 24, Page(s) 15483–15493

    Abstract: Targeted protein degradation with bifunctional degraders is positioned as a remarkable game-changing strategy to control cellular protein levels and promises a new therapeutic modality in drug discovery. Light activation of a degrader to achieve ... ...

    Abstract Targeted protein degradation with bifunctional degraders is positioned as a remarkable game-changing strategy to control cellular protein levels and promises a new therapeutic modality in drug discovery. Light activation of a degrader to achieve exquisite spatiotemporal control over protein stability in cells has attracted the interest of multiple research groups, with recent reports demonstrating optical control of proteolysis with chimeric molecules bearing photolabile or photoswitchable motifs. In this context of targeted proteolysis research spurring the emergence of innovative tools, we examine the design, synthesis, and properties of light-activated degraders. The significant impact of this approach in regulating disease-relevant protein levels in a light-dependent manner is highlighted with key examples, and future developments to fully harness the potential of light-induced protein degradation with photoactive bifunctional molecules are discussed.
    MeSH term(s) Animals ; Azo Compounds/chemistry ; Azo Compounds/pharmacology ; Cell Cycle Proteins/metabolism ; Cell Proliferation/drug effects ; Drug Design ; HeLa Cells ; Humans ; Light ; Proteasome Endopeptidase Complex/metabolism ; Protein Stability/radiation effects ; Proteins/metabolism ; Proteolysis/radiation effects ; Small Molecule Libraries/chemistry ; Small Molecule Libraries/pharmacology ; Transcription Factors/metabolism ; Ubiquitin-Protein Ligases/metabolism ; Zebrafish ; Zebrafish Proteins/chemistry ; Zebrafish Proteins/metabolism
    Chemical Substances Azo Compounds ; BRD4 protein, human ; Cell Cycle Proteins ; Proteins ; Small Molecule Libraries ; Transcription Factors ; Zebrafish Proteins ; Ubiquitin-Protein Ligases (EC 2.3.2.27) ; Proteasome Endopeptidase Complex (EC 3.4.25.1) ; azobenzene (F0U1H6UG5C)
    Language English
    Publishing date 2020-11-23
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.0c01542
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Bacterial enzymes: powerful tools for protein labeling, cell signaling and therapeutic discovery

    Liu, Lu / Gray, Janine L. / Tate, Edward W. / Yang, Aimin

    Trends in Biotechnology.

    2023  

    Abstract: Bacteria have evolved a diverse set of enzymes which enable them to subvert host defense mechanisms as well as to form part of the prokaryotic immune system. Due to their unique and varied biochemical activities, these bacterial enzymes have emerged as ... ...

    Abstract Bacteria have evolved a diverse set of enzymes which enable them to subvert host defense mechanisms as well as to form part of the prokaryotic immune system. Due to their unique and varied biochemical activities, these bacterial enzymes have emerged as key tools for understanding and investigating biological systems. In this review, we summarize and discuss some of the most prominent bacterial enzymes used for the site-specific modification of proteins, in vivo protein labeling, proximity labeling and interactome mapping, signaling pathway manipulation and in therapeutic discovery. Finally, we provide a perspective on the complementary advantages and limitations of using bacterial enzymes compared to chemical probes for exploring biological systems.
    Keywords biotechnology ; immune system ; therapeutics ; bacterial enzymes ; site-specific bioconjugation ; in vivo labeling ; proximity labeling ; signaling pathways ; therapeutic applications
    Publishing place Elsevier Ltd
    Document type Article ; Online
    Note Pre-press version
    ZDB-ID 47474-5
    ISSN 1879-3096 ; 0167-7799
    ISSN (online) 1879-3096
    ISSN 0167-7799
    DOI 10.1016/j.tibtech.2023.05.004
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Article ; Online: Evaluating Hedgehog Acyltransferase Activity and Inhibition Using the Acylation-coupled Lipophilic Induction of Polarization (Acyl-cLIP) Assay.

    Andrei, Sebastian A / Tate, Edward W / Lanyon-Hogg, Thomas

    Methods in molecular biology (Clifton, N.J.)

    2021  Volume 2374, Page(s) 13–26

    Abstract: Palmitoylation of the Hedgehog family of proteins is a critical step in the Hedgehog signaling pathway and is performed by the membrane-bound O-acyltransferase enzyme Hedgehog acyltransferase (HHAT). Measurement of HHAT activity has traditionally relied ... ...

    Abstract Palmitoylation of the Hedgehog family of proteins is a critical step in the Hedgehog signaling pathway and is performed by the membrane-bound O-acyltransferase enzyme Hedgehog acyltransferase (HHAT). Measurement of HHAT activity has traditionally relied on radiolabeled fatty acid substrates, which imposes considerable constraints on throughput, cost, and safety, consequently hindering the efficient identification and development of small-molecule HHAT inhibitors. The Acylation-coupled Lipophilic Induction of Polarisation (Acyl-cLIP) assay was recently developed in our lab as a novel platform to evaluate lipidation of peptides in real time and high throughput. In this chapter, we describe the isolation of active HHAT from HEK293a cells and application of the Acyl-cLIP assay to characterize HHAT inhibitors. Our methodology uses standard chemical biology lab equipment and yields high-quality kinetic data from minimal sample volumes. The assay uses standard 384-well plates and is easily adapted to medium- or high-throughput screening formats.
    MeSH term(s) Acylation ; Acyltransferases/metabolism ; Hedgehog Proteins/metabolism ; Lipoylation ; Surgical Instruments
    Chemical Substances Hedgehog Proteins ; Acyltransferases (EC 2.3.-)
    Language English
    Publishing date 2021-09-25
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-1701-4_2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Beyond targeted protein degradation: LD·ATTECs clear cellular lipid droplets.

    De Vita, Elena / Lucy, Daniel / Tate, Edward W

    Cell research

    2021  Volume 31, Issue 9, Page(s) 945–946

    MeSH term(s) Lipid Droplets/metabolism ; Proteolysis
    Language English
    Publishing date 2021-08-04
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 1319303-x
    ISSN 1748-7838 ; 1001-0602
    ISSN (online) 1748-7838
    ISSN 1001-0602
    DOI 10.1038/s41422-021-00546-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top